Quality of Life in Normogonadotropic Anovulation

Launched by JAGIELLONIAN UNIVERSITY · Jan 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how certain ovulation disorders, particularly polycystic ovary syndrome (PCOS) and other related conditions, affect the quality of life in women. Women with these disorders often experience irregular menstrual cycles and may face additional health challenges, such as weight gain, insulin resistance, and infertility. The researchers aim to understand how these conditions impact daily living and overall well-being.

To participate in this trial, women aged 18 to 45 who have menstrual cycles that are shorter than 21 days or longer than 35 days may be eligible. Unfortunately, those who have had previous ovarian surgery cannot take part. Participants will be asked to share their experiences and may undergo assessments to help researchers gather valuable information. This study is important as it could lead to better understanding and management of these ovulation disorders, ultimately improving the quality of life for many women.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • menstrual cycle length \<21 days or \>35 days
• • age 18-45 years
• Exclusion Criteria:
• • previous ovarian surgery